noom glp 1 program reviews Noom's GLP-1 Companion Receives Major Update to Prepare for New Expected Prescription Drug Use-Related Software (PDURS) Model Noom GLP-1 Review 2026: Great

Description

Gastrointestinal (GI) Nausea (most common, especially during the first few weeks)

Understanding this mechanism helps individuals and healthcare providers address constipation associated with GLP-1 therapies more effectively, tailoring interventions to support digestive health during the weight loss journey

Recurrent UTIs, defined as two or more infections in six months or three or more in twelve months, warrant thorough investigation regardless of medication status

Published: Aug 12, 2025 Written by Klarity Editorial Team Published: Aug 12, 2025 Last updated: June 3, 2026 Injection site reactions are one of the most common concerns for patients starting Zepbound (tirzepatide) or other GLP-1 medications for weight loss

Jeffs leadership has earned him numerous accolades, including recognition as Best Health Care Attorney and listings in Best Lawyers in America and Florida Legal Elite